C

CytoTools AG
XETRA:T5O

Watchlist Manager
CytoTools AG
XETRA:T5O
Watchlist
Price: 101.26 EUR 0.98% Market Closed
Market Cap: 52.8m EUR
Have any thoughts about
CytoTools AG?
Write Note

CytoTools AG
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

CytoTools AG
Total Current Assets Peer Comparison

Comparables:
BNTX
MOR
IMTX
BIO
FYB

Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
C
CytoTools AG
XETRA:T5O
Total Current Assets
€1.2m
CAGR 3-Years
-9%
CAGR 5-Years
-13%
CAGR 10-Years
-7%
BioNTech SE
NASDAQ:BNTX
Total Current Assets
€19.5B
CAGR 3-Years
127%
CAGR 5-Years
113%
CAGR 10-Years
N/A
MorphoSys AG
XETRA:MOR
Total Current Assets
€675m
CAGR 3-Years
-19%
CAGR 5-Years
13%
CAGR 10-Years
6%
Immatics NV
NASDAQ:IMTX
Total Current Assets
€449.4m
CAGR 3-Years
23%
CAGR 5-Years
227%
CAGR 10-Years
N/A
Biotest AG
XETRA:BIO
Total Current Assets
€738.9m
CAGR 3-Years
9%
CAGR 5-Years
9%
CAGR 10-Years
2%
Formycon AG
XETRA:FYB
Total Current Assets
€67.1m
CAGR 3-Years
10%
CAGR 5-Years
29%
CAGR 10-Years
N/A

See Also

What is CytoTools AG's Total Current Assets?
Total Current Assets
1.2m EUR

Based on the financial report for Jun 30, 2023, CytoTools AG's Total Current Assets amounts to 1.2m EUR.

What is CytoTools AG's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
-7%

Over the last year, the Total Current Assets growth was -72%. The average annual Total Current Assets growth rates for CytoTools AG have been -9% over the past three years , -13% over the past five years , and -7% over the past ten years .

Back to Top